Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma

被引:18
|
作者
Jiang, Y [1 ]
Zhou, XD [1 ]
Liu, YK [1 ]
Wu, X [1 ]
Huang, XW [1 ]
机构
[1] Fudan Univ, Liver Canc Inst, Zhong Shan Hosp, Shanghai 200032, Peoples R China
关键词
D O I
10.3748/wjg.v8.i5.804
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Hepatocellular carcinoma(HCC) is a significant health problem in China. But the molecular mechanisms of HCC remains unclear. APC/beta-Catenin/Tcf signaling pathway, also known as Wnt pathway, plays a critical role in the development and oncogenesis. As little is known about the alteration of human T-cell transcription factor-4 (hTcf-4) gene in HCC, it is of interest to study the expression and mutation of hTcf-4 gene in HCC and the relationship between hTcf-4 gene and progression of HCC. METHODS: Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect the expression of hTcf-4 mRNA in 32 HCC and para-cancerous tissues and 5 normal liver tissues. PCR-single strand conformation polymorphism (PCR-SSCP) method was used to detect the mutation of hTcf-4 exons 1, 4, 9 and 15 in HCC. The correlation of expression and mutation of the hTcf-4 gene with clinicopathological characteristics of HCC was also analyzed. RESULTS: RT-PCR showed that the expression rate of hTcf-4 mRNA in HCC, para-cancerous tissues and normal liver tissues was 90.6 %, 71.9 % and 80 %, respectively. The gene expression level in tumor was 0.71 +/- 0.13, much higher than that in para-cancerous liver 0.29 +/- 0.05 and normal liver 0.26 +/- 0.05 (P<0.001), although there was no significant difference in gene expression level between para-cancerous tissues and normal liver (P >0.05). Furthermore, hTcf-4 gene expression was closely associated with tumor capsule status and intrahepatic metastasis of HCC. On SSCP, 2 of 32 cases of HCC (6.25 %) displayed characteristic mutational mobility shifts in exon 15 of the hTcf-4 gene. No abnormal shifting bands were observed in para-cancerous tissues. CONCLUSION: The high expression level of hTcf-4 in HCC, especially in tumors with metastasis, suggests that the overexpression of hTcf-4 gene may be closely associated with development and progression of HCC, but the mutation of this gene seemed to play less important role in this respect.
引用
收藏
页码:804 / 807
页数:4
相关论文
共 50 条
  • [1] Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma
    Ying Jiang Xin-Da Zhou Yin-Kun Liu Xin Wu Xiao-Wu Huang Liver Cancer Institute
    World Journal of Gastroenterology, 2002, 8 (05) : 804 - 807
  • [2] Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma
    Zhou, Xu
    Lu, Jun
    Zhu, Huaqiang
    ONCOLOGY LETTERS, 2016, 11 (01) : 111 - 115
  • [3] Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma
    Jiang, Liang
    Liu, Qiu-Long
    Liang, Qi-Lian
    Zhang, Hui-Jie
    Ou, Wen-Ting
    Yuan, Gao-Le
    ONCOLOGY LETTERS, 2018, 15 (01) : 545 - 551
  • [4] Association between G-protein coupled receptor 4 expression and microvessel density, clinicopathological characteristics and survival in hepatocellular carcinoma
    Xue, Chaofan
    Shao, Shuai
    Yan, Yanli
    Yang, Si
    Bai, Shuheng
    Wu, Yinying
    Zhang, Jiangzhou
    Liu, Rui
    Ma, Hailin
    Chai, Linyan
    Zhang, Xiaozhi
    Ren, Juan
    ONCOLOGY LETTERS, 2020, 19 (04) : 2609 - 2620
  • [5] Association between Osteopontin and EGFR Expression with Clinicopathological Parameters in Hepatocellular Carcinoma
    Tsai, Wen-Chiuan
    Lee, Herng-Sheng
    Jin, Jong-Shiaw
    Gao, Hong-Wei
    Chao, Tai-Kuang
    Chen, Ann
    Nieh, Shin
    Chan, De-Chuan
    Chang, Fei-Ni
    Lin, Chih-Kung
    CHINESE JOURNAL OF PHYSIOLOGY, 2012, 55 (06): : 412 - 420
  • [6] Clinicopathological Characteristics of Steatohepatitic Hepatocellular Carcinoma
    Taniai, Makiko
    Hashimoto, Etsuko
    Ikarashi, Yuichi
    Kodama, Kazuhisa
    Kogiso, Tomomi
    Torii, Nobuyuki
    Tokushige, Katsutoshi
    HEPATOLOGY, 2016, 64 : 648A - 649A
  • [7] Clinicopathological Characteristics of Hepatocellular Carcinoma in Turkey
    Dogan, Erkan
    Yalcin, Suayib
    Koca, Dogan
    Olmez, Aydemir
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (06) : 2985 - 2990
  • [8] Association between the expression of carbonic anhydrase II and clinicopathological features of hepatocellular carcinoma
    Zhang, Hui
    Zhuo, Changhua
    Zhou, Dong
    Zhang, Fan
    Chen, Minyong
    Xu, Shaohua
    Chen, Zhaoshuo
    ONCOLOGY LETTERS, 2019, 17 (06) : 5721 - 5728
  • [9] The association of PDRG1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma
    Yang, Xiaodong
    Guan, Xin-yuan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S14 - S14
  • [10] Survivin expression in hepatocellular carcinoma. Correlation with clinicopathological characteristics and overall survival
    Kapiris, Ioannis
    Nastos, Konstantinos
    Karakatsanis, Anestis
    Theodosopoulos, Theodosios
    Karandrea, Despoina
    Kondi-Pafiti, Agatha
    Contis, John
    JOURNAL OF BUON, 2019, 24 (05): : 1934 - 1942